Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,484,207
+$495,677 QoQ
Shares Held
13,846
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.04%
of 13F equity value
Holder Rank
#1,545
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARINO, STRAM & ASSOCIATES LLC holds $17,844,670 across 8 Drug Manufacturers - General names. ABBV ranks #3 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,721 | $3,738,692 | |
| 2 | LLY |
ELI LILLY & Co
|
3,091 | $3,707,438 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
13,846 | $3,484,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,413 | $3,137,070 | |
| 5 | AMGN |
Amgen Inc
|
5,457 | $1,976,088 | |
| 6 | PFE |
Pfizer Inc
|
31,798 | $765,695 | |
| 7 | NVS |
Novartis AG
|
4,413 | $691,605 | |
| 8 | GSK |
GSK plc
|
6,560 | $343,875 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,484,207 | 13,846 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $2,988,530 | 13,741 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $3,107,007 | 13,598 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $3,389,745 | 14,640 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,511,809 | 13,532 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $2,782,425 | 13,280 | Shares | Defined | 2025-04-21 | |
| 2024-12-31 | $2,386,333 | 13,429 | Shares | Defined | 2025-01-17 | |
| 2024-09-30 | $2,664,005 | 13,490 | Shares | Defined | 2024-10-21 | |
| 2024-06-30 | $2,330,442 | 13,587 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,464,905 | 13,536 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,042,349 | 13,179 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,959,244 | 13,144 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,782,343 | 13,229 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $2,151,335 | 13,499 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,208,400 | 13,665 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,755,198 | 13,078 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,982,349 | 12,943 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,097,703 | 12,940 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,722,017 | 12,718 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,325,398 | 12,287 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,852,590 | 16,447 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,166,070 | 10,775 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,079,964 | 10,079 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $867,228 | 9,901 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $894,125 | 9,107 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $542,625 | 7,122 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||